Optimal treatment strategy with nilotinib for patients with...

  • Main
  • 2020 / 04
  • Optimal treatment strategy with nilotinib for patients with...

Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic-phase chronic myeloid leukemia based on early achievement of deep molecular response (MR 4.5 ): The phase 2, multicenter N-Road study

Nishiwaki, Kaichi, Sugimoto, Kei-ji, Tamaki, Shigehisa, Hisatake, Junichi, Yokoyama, Hisayuki, Igarashi, Tadahiko, Shinagawa, Atsushi, Sugawara, Takeaki, Hara, Satoru, Fujikawa, Kazuhisa, Shimizu, Sei
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer Medicine
DOI:
10.1002/cam4.3034
Date:
April, 2020
File:
PDF, 561 KB
2020
Conversion to is in progress
Conversion to is failed